Skip to main content

Table 1 Clinical characteristics of neuroblastoma patients

From: Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

  Number Percent of total
MYCN status   
 Normal 401 80.5 %
 Amplified 92 18.5 %
 N.A. 5 1.0 %
INSS stage   
 1 121 24.3 %
 2 78 15.7 %
 3 63 12.7 %
 4 183 36.7 %
 4S 53 10.6 %
Age at diagnosis   
 <18 months 300 60.2 %
 >18 months 198 39.8 %
Sex   
 Male 278 55.8 %
 Female 205 41.2 %
 N.A. 15 3.0 %
High-risk patients 176 35.3 %
  1. NA, not available